Cargando…
Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684641/ https://www.ncbi.nlm.nih.gov/pubmed/38017059 http://dx.doi.org/10.1038/s41598-023-48298-9 |
| _version_ | 1785151448449810432 |
|---|---|
| author | Xie, Fang Huang, Mei Lin, Xiansheng Liu, Chenhai Liu, Zhen Meng, Futao Wang, Chao Huang, Qiang |
| author_facet | Xie, Fang Huang, Mei Lin, Xiansheng Liu, Chenhai Liu, Zhen Meng, Futao Wang, Chao Huang, Qiang |
| author_sort | Xie, Fang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10684641 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106846412023-11-30 Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine Xie, Fang Huang, Mei Lin, Xiansheng Liu, Chenhai Liu, Zhen Meng, Futao Wang, Chao Huang, Qiang Sci Rep Retraction Note Nature Publishing Group UK 2023-11-28 /pmc/articles/PMC10684641/ /pubmed/38017059 http://dx.doi.org/10.1038/s41598-023-48298-9 Text en © The Publisher 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Xie, Fang Huang, Mei Lin, Xiansheng Liu, Chenhai Liu, Zhen Meng, Futao Wang, Chao Huang, Qiang Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title | Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title_full | Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title_fullStr | Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title_full_unstemmed | Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title_short | Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| title_sort | retraction note: the bet inhibitor i-bet762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684641/ https://www.ncbi.nlm.nih.gov/pubmed/38017059 http://dx.doi.org/10.1038/s41598-023-48298-9 |
| work_keys_str_mv | AT xiefang retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT huangmei retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT linxiansheng retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT liuchenhai retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT liuzhen retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT mengfutao retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT wangchao retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine AT huangqiang retractionnotethebetinhibitoribet762inhibitspancreaticductaladenocarcinomacellproliferationandenhancesthetherapeuticeffectofgemcitabine |